G9a inhibition by CM-272: Developing a novel anti-tumoral strategy for castration-resistant prostate cancer using 2D and 3D in vitro models.
Moreira-Silva F, Outeiro-Pinho G, Lobo J, Guimarães R, Gaspar VM, Mano JF, Agirre X, Pineda-Lucena A, Prosper F, Paramio JM, Henrique R, Correia MP, Jerónimo C.
Moreira-Silva F, et al. Among authors: gaspar vm.
Biomed Pharmacother. 2022 Jun;150:113031. doi: 10.1016/j.biopha.2022.113031. Epub 2022 Apr 25.
Biomed Pharmacother. 2022.
PMID: 35483199
Free article.